β-Cell Differentiation from a Human Pancreatic Cell Line in Vitro and in Vivo

Cell transplantation therapy for diabetes is limited by an inadequate supply of cells exhibiting glucose-responsive insulin secretion. To generate an unlimited supply of human β-cells, inducibly transformed pancreatic β-cell lines have been created by expression of dominant oncogenes. The cell lines grow indefinitely but lose differentiated function. Induction of β-cell differentiation was achieved by stimulating the signaling pathways downstream of the transcription factor PDX-1, cell-cell contact, and the glucagon-like peptide (GLP-1) receptor. Synergistic activation of those pathways resulted in differentiation into functional β-cells exhibiting glucose-responsive insulin secretion in vitro. Both oncogene-expressing and oncogene-deleted cells were transplanted into nude mice and found to exhibit glucose-responsive insulin secretion in vivo. The ability to grow unlimited quantities of human β-cells is a major step toward developing a cell transplantation therapy for diabetes.

[1]  F. Levine.  Gene therapy for diabetes: strategies for β‐cell modification and replacement , 1997 .

[2]  F. Levine,et al.  PDX-1 and cell-cell contact act in synergy to promote delta-cell development in a human pancreatic endocrine precursor cell line. , 2000, Molecular endocrinology.

[3]  Ana D. Lopez,et al.  Developmental Gene Expression in the Human Fetal Pancreas , 1994, Pediatric Research.

[4]  W. Rutter,et al.  The Insulin Gene Promoter: A Simplified Nomenclature , 1995, Diabetes.

[5]  Ana D. Lopez,et al.  Sustained proliferation of PDX-1+ cells derived from human islets. , 1999, Diabetes.

[6]  F. Levine,et al.  Accelerated telomere shortening and senescence in human pancreatic islet cells stimulated to divide in vitro. , 2000, The Journal of endocrinology.

[7]  J. Reig,et al.  Insulin-secreting cells derived from embryonic stem cells normalize glycemia in streptozotocin-induced diabetic mice. , 2000, Diabetes.

[8]  R. Weiss.  Transgenic pigs and virus adaptation , 1998, Nature.

[9]  E. Ryan,et al.  Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen. , 2000, The New England journal of medicine.

[10]  R. Stein,et al.  The role of the insulin control element and RIPE3b1 activators in glucose-stimulated transcription of the insulin gene. , 1995, Molecular endocrinology.

[11]  Ana D. Lopez,et al.  Growth Factor/Matrix-Induced Proliferation of Human Adult β-Cells , 1995, Diabetes.

[12]  S. Bonner-Weir,et al.  In vitro cultivation of human islets from expanded ductal tissue. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[13]  Jie Zhou,et al.  Glucagon-like peptide 1 and exendin-4 convert pancreatic AR42J cells into glucagon- and insulin-producing cells. , 1999, Diabetes.

[14]  S. Bonner-Weir,et al.  Exendin-4 stimulates both beta-cell replication and neogenesis, resulting in increased beta-cell mass and improved glucose tolerance in diabetic rats. , 1999, Diabetes.

[15]  C. Ricordi,et al.  Nicotinamide is a potent inducer of endocrine differentiation in cultured human fetal pancreatic cells. , 1993, The Journal of clinical investigation.

[16]  D. Harlan,et al.  Long-term survival and function of intrahepatic islet allografts in rhesus monkeys treated with humanized anti-CD154. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[17]  D. Drucker,et al.  Exendin-(9-39) is an inverse agonist of the murine glucagon-like peptide-1 receptor: implications for basal intracellular cyclic adenosine 3',5'-monophosphate levels and beta-cell glucose competence. , 1998, Endocrinology.

[18]  O. Korsgren,et al.  Xenoislet transplantation: experimental and clinical aspects , 1999, Journal of Molecular Medicine.

[19]  M. Hussain,et al.  Glucagon-like peptide 1 stimulates insulin gene promoter activity by protein kinase A-independent activation of the rat insulin I gene cAMP response element. , 2000, Diabetes.

[20]  T. Hanafusa,et al.  Betacellulin and activin A coordinately convert amylase-secreting pancreatic AR42J cells into insulin-secreting cells. , 1996, The Journal of clinical investigation.

[21]  Ana D. Lopez,et al.  A role for activin A and betacellulin in human fetal pancreatic cell differentiation and growth. , 2000, The Journal of clinical endocrinology and metabolism.

[22]  G. Beattie,et al.  Experimental transplantation of human fetal and adult pancreatic islets. , 1997, The Journal of clinical endocrinology and metabolism.

[23]  G. Leibowitz,et al.  Telomerase Activity Is Sufficient To Allow Transformed Cells To Escape from Crisis , 1999, Molecular and Cellular Biology.

[24]  F. Levine,et al.  Development of a VSV-G protein pseudotyped retroviral vector system expressing dominant oncogenes from a lacO-modified inducible LTR promoter. , 1996, Gene.

[25]  F. Levine,et al.  Acid beta-galactosidase: a developmentally regulated marker of endocrine cell precursors in the human fetal pancreas. , 1994, The Journal of clinical endocrinology and metabolism.

[26]  Ana D. Lopez,et al.  Hepatocyte Growth Factor/Scatter Factor Has Insulinotropic Activity in Human Fetal Pancreatic Cells , 1994, Diabetes.

[27]  T. Otonkoski,et al.  Growth Factor-Mediated Proliferation and Differentiation of Insulin-Producing INS-1 and RINm5F Cells: Identification of Betacellulin as a Novel β-Cell Mitogen. , 1998, Endocrinology.

[28]  D. Drucker.  Glucagon-Like Peptides , 1998, Diabetes.

[29]  M. Itakura,et al.  Hypoplasia of pancreatic islets in transgenic mice expressing activin receptor mutants. , 1998, The Journal of clinical investigation.

[30]  John H. Luft,et al.  IMPROVEMENTS IN EPOXY RESIN EMBEDDING METHODS , 1961, The Journal of biophysical and biochemical cytology.

[31]  P. Halban,et al.  Novel Insulinoma Cell Lines Produced by Iterative Engineering of GLUT2, Glucokinase, and Human Insulin Expression , 1997, Diabetes.

[32]  F. Levine,et al.  Isolation and characterization of a cell line from the epithelial cells of the human fetal pancreas. , 1997, Cell transplantation.

[33]  G M Edelman,et al.  Targeted DNA recombination in vivo using an adenovirus carrying the cre recombinase gene. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[34]  B. Glaser,et al.  Pancreatic beta-cell glucokinase: closing the gap between theoretical concepts and experimental realities. , 1998, Diabetes.